Catheterization and Cardiovascular Interventions
Volume 97, Issue 6 pp. 1268-1269
EDITORIAL COMMENT

Tailwind of transcatheter mitral valve repair pushes forward the treatment of acute mitral regurgitation after myocardial infarction

Giuseppe Tarantini MD, PhD, FESC, 

Corresponding Author

Giuseppe Tarantini MD, PhD, FESC

Department of Cardiac, Thoracic, Vascular Science and Public Health, University of Padova, Padova, Italy

Correspondence

Giuseppe Tarantini, Department of Cardiac, Thoracic, Vascular Science and Public Health, University of Padova, Via Giustiniani 2, 35128 Padova, Italy.

Email: [email protected]

Search for more papers by this author
Chiara Fraccaro MD, PhD, 

Chiara Fraccaro MD, PhD

Department of Cardiac, Thoracic, Vascular Science and Public Health, University of Padova, Padova, Italy

Search for more papers by this author
First published: 11 May 2021
https://doi.org/10.1002/ccd.29728
Expert Article Analysis for: Use of MitraClip for mitral valve repair in patients with acute mitral regurgitation following acute myocardial infarction: Effect of cardiogenic shock on outcomes (IREMMI Registry)

Key Points

  • Acute mitral regurgitation after myocardial infarction is associated with high mortality and morbidity.
  • Treatment with the MitraClip is associated with high procedural success and acceptable mortality whether they presented in or out of cardiogenic shock, provided initial hemodynamic stabilization was first achieved before PMVR.
  • This transcatheter technique represents a valid alternative for selected patients and prospective studies are warranted to inform patient selection and periprocedural management in this acute setting.

CONFLICT OF INTEREST

Giuseppe Tarantini received speakers' fees from Abbott and Edwards Lifescience; Chiara Fraccaro declared no conflicts regarding this publication.

The full text of this article hosted at iucr.org is unavailable due to technical difficulties.